Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $14,190 - $31,284
3,300 New
3,300 $22,000
Q1 2021

May 17, 2021

SELL
$110.45 - $164.47 $397,620 - $592,092
-3,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$60.78 - $154.03 $218,808 - $554,508
3,600 New
3,600 $529,000
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $288,320 - $379,328
-6,400 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$42.74 - $66.25 $273,536 - $424,000
6,400 New
6,400 $346,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.